title: A study of borderline positive Hybrid Capture 2 tests in the Kaiser Permanente Northern California cervical screening program: evidence against retesting.
authors: Kaiser Permanente Northern California, Women's Health Research Institute, Division of Research, Oakland, CA 94710, USA.brandon.j.lamere@kp.org
authors: Brandon J
authors: BJ
authors: Lamere
authors: Philip E
authors: PE
authors: Castle
authors: Barbara
authors: B
authors: Fetterman
authors: Nancy
authors: N
authors: Poitras
authors: Mark
authors: M
authors: Stanley
authors: Jen
authors: J
authors: Shieh
authors: Thomas
authors: T
authors: Lorey
authors: Walter
authors: W
authors: Kinney
authors: Mark
authors: M
authors: Schiffman
mesh_terms: D002140:California; D055088:Early Detection of Cancer / Q000379:methods*; D005260:Female; D006279:Health Maintenance Organizations; D006801:Humans; D007348:Insurance, Health; D008403:Mass Screening; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000517:prevention & control*
references: Br J Cancer. 2010 Sep 28;103(7):939-46
references: 20808310
references: Diagn Mol Pathol. 2007 Sep;16(3):125-9
references: 17721319
references: J Clin Pathol. 2002 Apr;55(4):244-65
references: 11919208
references: Lancet. 2002 Jul 20;360(9328):228-9
references: 12133661
references: BMJ. 2011 May 23;342:d2757
references: 21606136
references: BMJ. 2011 May 23;342:d2941
references: 21606137
references: Vaccine. 2008 Aug 19;26 Suppl 10:K29-41
references: 18847555